Interferon-Free Study Boosts Belief in Sofosbuvir
Share
Follow Us
The Editors at Hepatitis Central
April 25, 2013
Sofosbuvir and ribavirin show a high response rate for Hepatitis C genotypes 2 and 3 in a Phase 3 study at Weil Cornell Medical Center.
New Hepatitis C Drug Continues Curing In Clinical Trials
As clinical trials continue to show positive results, sofosbuvir seems to be poised to gain FDA approval.
By Jonathan Weiss | Apr 24, 2013
Coming on the heels of a recent report indicating that the Hepatitis C drug sofosbuvir surpassed expectations, a Phase III clinical trial out of Weil Cornell Medical Center in New York City has shown that the result of using the drug cures most patients with two subtypes of the virus.
Continue reading this entire article:
http://www.medicaldaily.com/new-hepatitis-c-drug-continues-curing-clinical-trials-245236
